With box warnings

Without box warnings

Branded

Generic

2 results

imfinzi
(Durvalumab)
AstraZeneca Pharmaceuticals LP
Usage: IMFINZI is indicated for various cancers, including resectable non-small cell lung cancer (NSCLC), unresectable Stage III NSCLC, small cell lung cancer (SCLC), biliary tract cancer, hepatocellular carcinoma, advanced or recurrent endometrial cancer, and muscle invasive bladder cancer in combination with other treatments.
opdivo
(nivolumab)
E.R. Squibb & Sons, L.L.C.
Usage: OPDIVO is indicated for the treatment of various cancers, including unresectable/metastatic melanoma, neoadjuvant and adjuvant non-small cell lung cancer, metastatic non-small cell lung cancer, malignant pleural mesothelioma, advanced renal cell carcinoma, classical Hodgkin lymphoma, and others. It is used in different combinations and settings based on the cancer type.

Medications for Resectable Nonsmall Cell Lung Cancer

imfinzi